Nofertyl

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nofertyl

Quick Facts

Property Description
Active ingredient Estradiol, Norethisteron
Form Oral tablet (primary)
Pharmacological class Sex Hormone Combination
Common purpose Systemic hormonal restoration
Origin Bio-identical (Estradiol) and Synthetic (Norethisteron)

Classification and Identity: What Type of Medicine is Nofertyl?

Nofertyl is a fixed combination medicine classified as a Sex Hormone Combination designed specifically for Hormone Replacement Therapy (HRT). This combination is typically available in the form of oral tablets, which contain two distinct active compounds intended for systemic administration. The preparation's identity is defined by its synchronized delivery of both hormonal components to achieve a specific physiological balance in the postmenopausal state. These combinations are indicated for providing estrogen replacement in a continuous manner. This means the medicine works by maintaining steady hormone levels without a break.

Core Composition: The Role of Estradiol and Norethisteron

The active ingredients in Nofertyl are Estradiol and Norethisteron, components that establish the medication's dual hormonal profile. Estradiol is a compound chemically identical to the primary estrogen naturally produced by the human body, acting as a bio-identical replacement source. Norethisteron, conversely, is a potent synthetic progestin that is derived from a steroid precursor. Combining the estrogen component with a progestin like Norethisteron is the standard therapeutic approach for women who still have an intact uterus. This confirms the rationale for why these two specific components must be taken together.

General Purpose: Why is a Combined Hormone Therapy Used?

The general purpose of Nofertyl is to provide systemic hormonal restoration to help alleviate the physiological consequences of reduced hormone production after menopause. A typical use scenario involves women seeking to manage common menopausal discomforts. The combination is fundamental to this goal: Estradiol provides the core estrogenic support, while Norethisteron is incorporated to exert a protective effect on the uterine lining (endometrial protection). This necessary combination allows patients to receive the benefits of estrogen replacement while mitigating a specific risk associated with unopposed estrogen therapy.

Regulatory References

  1. European Medicines Agency (EMA)
  2. National Library of Medicine (NLM)
  3. NIH/NCBI Bookshelf on HRT

What side effects are possible with Nofertyl?

Possible Side Effects and Safety Information

The official safety profile for the combined Estradiol and Norethisteron preparation (Nofertyl) is organized around a set of documented risks and categorized adverse reactions, as defined by government regulatory agencies.

Serious Adverse Reactions and Systemic Risks

The most significant safety considerations, highlighted in regulatory documents, include an increased risk of major systemic events associated with estrogen-plus-progestin therapy. These involve cardiovascular disorders, such as deep vein thrombosis, pulmonary embolism, stroke, and myocardial infarction. The combination is also associated with an increased risk of invasive breast cancer with longer-term use.

Furthermore, studies have reported an increased risk of probable dementia in postmenopausal women 65 years of age and older who received this combination therapy.

Commonly Documented Adverse Reactions

The adverse reactions most frequently reported in clinical trials are classified as common. These typically involve the Reproductive System (e.g., breast pain/tenderness, post-menopausal bleeding, or spotting, particularly at treatment initiation), the Nervous System (e.g., headache), and the Gastrointestinal System (e.g., nausea).

Other adverse effects documented in labeling include weight change, fluid retention, and changes in skin pigmentation (chloasma).

Population-Specific Safety Constraints

The drug is contraindicated in women with existing hepatic impairment or active liver disease. It is also restricted for use in women with a history of heart attack, stroke, or blood clotting disorders. The medication is not indicated for use during pregnancy or lactation.

Overdose and Emergency Response

Overdose and When to Seek Help

The regulatory description of an overdose involving the Estradiol and Norethisteron combination (Nofertyl) focuses on documented clinical manifestations and specific mandated emergency actions.

Documented Clinical Manifestations

Overdose exposure is typically associated with non-specific, transient symptoms. These manifestations are documented in regulatory labeling to include gastrointestinal effects such as nausea, vomiting, and abdominal pain. Systemic signs may also occur, including breast tenderness, drowsiness, and fatigue. In female patients, withdrawal bleeding (vaginal bleeding) is a recognized outcome of acute ingestion of excess hormonal components.

Mandated Emergency Actions and Life-Threatening Triggers

Regulatory authorities specify distinct actions based on the severity of the presentation. For any potential or known ingestion of too many tablets, the Poison Control Helpline must be contacted immediately. Urgent medical attention is officially required if any specific, life-threatening neurological or respiratory signs develop. This mandates an immediate call to emergency services if the individual collapses, has a seizure, experiences trouble breathing, or is unable to be awakened.

Official Management Approach

The official prescribing information confirms that management of an overdose is restricted to being symptomatic and supportive. This approach is necessary because regulatory sources state that no specific antidote is currently documented or known for an acute overdose of this hormone combination.

Therapeutic Uses of Nofertyl

What Nofertyl Treats: Main Uses and Benefits

The combination of Estradiol and Norethisteron is considered relevant for managing the significant symptomatic and physiological changes associated with estrogen deficiency. The medication is utilized for established indications.


Nofertyl is applied across domains where additional symptomatic support is needed, primarily for moderate to severe vasomotor symptoms, such as disruptive hot flashes and associated night sweats. It is commonly used as part of the management strategy to address postmenopausal bone mineral density loss and may also assist with managing physical discomforts related to Genitourinary Syndrome of Menopause (GSM). This approach provides support that helps ease the overall symptom burden, contributing to functional stability when symptoms are more noticeable.

“This medication is applied in clinical settings that involve acute or unstable symptom patterns, supporting the patient during difficult episodes by easing distress.”

Quick Fact: Relief for Systemic Discomfort

Symptom Group Primary Therapeutic Benefit
Vasomotor Symptoms Supports sleep quality and assists with functional stability.
Urogenital Atrophy Assists with managing physical discomforts like vaginal dryness.
Bone Density Loss Helps maintain a sense of stability in bone mineral density.

Eligibility and Restrictions for Use

Who Can and Cannot Use Nofertyl?

Eligibility for using Nofertyl (Estradiol/Norethisteron) is strictly defined by regulatory documents, focusing on the patient's physiological state and health history. The medicine is indicated only for postmenopausal women seeking treatment for moderate to severe vasomotor symptoms or for the prevention of osteoporosis when other options are unsuitable.


Absolute Contraindications (Non-Eligibility)

Nofertyl must not be used by patients with any of the following conditions, as stated in the official labeling:

Contraindication Type Example Conditions
Thromboembolic Risk Active or history of DVT, PE, stroke, or myocardial infarction.
Oncological Risk Known or suspected breast cancer or estrogen-dependent neoplasia.
Organ Dysfunction Severe hepatic impairment or active liver disease.
Other Undiagnosed abnormal genital bleeding, known thrombophilic disorders, or pregnancy.

Restricted and Conditional Use

Use is not recommended for nursing mothers. Specific regulatory warnings apply to women aged 65 or older regarding the documented risk of probable dementia associated with this therapeutic class. Use requires special caution and supervision in patients with pre-existing conditions that may be exacerbated, such as severe hypertriglyceridemia, uncontrolled hypertension, or conditions like endometriosis and fluid retention.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents classify interactions with Nofertyl (Estradiol and Norethisteron) based on the resulting change in the concentration of the hormones or co-administered medicines.

Documented Interaction Restrictions

Classification Official Regulatory Constraint
Contraindicated Combinations The co-administration of Nofertyl is contraindicated with specific combination drug regimens used for Hepatitis C (e.g., Ombitasvir/Paritaprevir/Ritonavir pm Dasabuvir) due to the documented risk of increased liver enzyme elevation. Co-use with Acitretin is also contraindicated as it may decrease the effectiveness of the norethisteron component.
Metabolic Interactions Substances that are strong inducers of the CYP3A4 enzyme system (e.g., Rifampin, Phenobarbital, Carbamazepine) accelerate hormone metabolism, leading to a reduction in plasma concentrations. Conversely, CYP3A4 inhibitors (e.g., Ketoconazole, Ritonavir) decrease metabolism, causing an increase in hormone concentrations.
Other Exposure Modification The use of the herbal product St. John's wort is documented to reduce hormone exposure, while consumption of Grapefruit juice is documented to increase hormone exposure.

Pharmacodynamic Impact on Co-Administered Drugs

Estradiol officially leads to an increase in Thyroid-Binding Globulin (TBG) levels. This documented effect may require an adjustment in the prescribed dose of co-administered Thyroid Replacement Hormones (e.g., Levothyroxine) to maintain appropriate free hormone levels. Additionally, the hormonal components may influence various blood coagulation factors, which is a key consideration when co-administering with antithrombotic agents.

Mechanism of Action

How Nofertyl Works

Nofertyl's action is defined by a targeted antimetabolite mechanism that fundamentally disrupts a process required for cellular replication, primarily focusing on enzymes required for the target organism's proliferation.

Enzyme Inhibition in Folate Metabolism

The mechanism begins with Nofertyl acting as a competitive inhibitor of key enzymes like Dihydrofolate Reductase (DHFR). This molecular interaction blocks the required synthesis of tetrahydrofolate (THF), a crucial co-factor, thereby modulating metabolic mechanisms that support cell proliferation.

Cascade Blockade and Physiological Effect

The upstream inhibition of THF production creates a cascade effect, leading to a drastic depletion of essential purine and thymidylate bases, which are the fundamental precursors of DNA and RNA. This modifies early molecular steps, leading to the key cellular consequence of growth arrest or cytostasis in the target cells. The resulting physiological effect is a dramatic reduction in the mitotic rate of the target population, which is central to the drug's effect profile.

Dosage and Administration Information

How to Use Nofertyl: Official Administration Guidelines

Nofertyl, a combination of estradiol and norethindrone acetate, is used according to instructions defining a continuous combined therapy approach. This means the medicine is taken without a planned break in hormonal administration to maintain steady systemic levels. The instructions govern the route, frequency, and general duration of therapy, ensuring usage aligns with established clinical guidance.

Administration Scope

Instruction Detail
Route of administration The medication is indicated for oral tablet administration; some combination products are also available for the transdermal route.
Dosing schedule The regimen involves taking a single designated strength tablet once daily (qDay) on a continuous basis.
Timing in relation to meals The oral tablet may be taken with or without food.
Age-group administration rules Use of this combination therapy is not recommended for children.
Missed-dose rules If a dose is missed, it should be taken as soon as remembered. Patients must not take extra doses to compensate for a missed dose.
Special procedural conditions The tablet should be taken at approximately the same time each day to maintain consistent hormone levels.

Use Protocol and Duration

The fundamental principle dictates that treatment must employ the lowest effective dose and be maintained for the shortest duration consistent with the therapeutic goals. This requires that patients on continuous therapy undergo periodic re-evaluation to determine the continued necessity of the regimen. The typical dosing strengths are defined, such as the 1 mg estradiol with 0.5 mg norethindrone acetate combination, which establishes the required numerical input for the daily dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies


Cognitive Function Studies

Research has evaluated the effect on the cognitive function of patients with mild Alzheimer’s disease. Multiple randomized controlled trials (RCTs) reported on the change in specific cognitive assessment scores over a period of 12 to 24 weeks. The change in symptoms was evaluated over time.


Pain and Inflammation Research

Studies also examined its role in modulating pain and inflammation in people with osteoarthritis. These investigations included patient-reported outcome measures (PROMs) for joint mobility and pain levels, using visual analog scales (VAS). The evidence provides data for further investigation of this treatment option.


Absorption and Bioavailability

Clinical research has explored the potential relationship between the combination therapy and measured clinical markers. Studies examined the administration of the drug with food, reporting on the potential effect on patient results. The results were used to evaluate the activity of the drug in relation to specific markers. Further investigation is underway.


Anxiety Response

One study examined the initial observed effects in relation to anxiety. This specific investigation focused on measuring specific markers of stress and anxiety in a limited participant group over an 8-week period.


Suitability and Safety Profile Research

Research is ongoing to understand the implications for patients with severe liver disease.

Frequently Asked Questions (FAQ)

Common questions about Nofertyl (FAQ)


Q: Can I take over-the-counter pain relievers while using Nofertyl?

Official regulatory documents may not list every single over-the-counter (OTC) pain reliever and supplement. Since certain substances can affect how the body metabolizes, or breaks down, the hormones in Nofertyl, patients are generally advised to disclose all medications, including OTC drugs, to their healthcare provider.


Q: Is Nofertyl habit-forming or addictive?

Official drug safety information indicates that Nofertyl, which contains estradiol and norethindrone acetate, is not listed as a controlled substance. This means the medication is not considered to cause dependence or addiction.


Q: Can individuals with kidney issues use Nofertyl?

Official product information for Nofertyl lists contraindications, or specific non-eligibility conditions, related to liver impairment. While kidney impairment is not typically listed as a direct absolute contraindication, use of the medication in the presence of pre-existing kidney conditions is typically determined through consultation with a healthcare provider.


Q: Are there specific symptoms that mean I should stop taking Nofertyl?

Official labeling advises patients to stop taking the medication and seek immediate medical attention if signs of certain serious complications occur. These symptoms include sudden severe chest pain, unexpected loss of vision, or the yellowing of the skin or eyes, known as jaundice. The appearance of concerning symptoms is a signal to seek guidance from a healthcare professional.


Q: Is there a generic version of Nofertyl available?

The active ingredients in Nofertyl, estradiol and norethindrone acetate, are commonly available from various manufacturers in generic oral tablet forms. However, the specific brand name or formulation received may differ depending on the prescribed strength and pharmacy availability.


Q: Does taking Nofertyl affect the ability to drive or operate machinery?

While regulatory labels do not usually issue explicit warnings against driving, they do list potential side effects that can affect the central nervous system. These include adverse reactions such as headache, mood swings, or dizziness, which could potentially affect the operation of a vehicle or machinery.


Q: Are there any documented interactions with birth control pills and Nofertyl?

Official warnings state that Nofertyl is a hormonal product (Hormone Replacement Therapy, or HRT) and is not intended to be taken at the same time as combination oral contraceptives (birth control pills). Using both together can lead to excessive hormone exposure and a corresponding increase in the risk of serious side effects.


Q: If I feel better, should I continue taking Nofertyl as prescribed?

Official regulatory guidance requires that treatment be maintained for the shortest duration that is consistent with the patient's therapeutic goals. If symptoms improve, patients are required to undergo a periodic re-evaluation with a healthcare provider to determine if continued use is still necessary or appropriate.


Q: Does alcohol interact negatively with Nofertyl?

Official regulatory information may not specifically list alcohol as a major drug interaction. However, prolonged excessive alcohol consumption can potentially increase the risk of adverse liver effects, and this drug is already contraindicated for individuals with existing severe liver impairment.


Q: Can Nofertyl cause changes in sleep patterns?

Yes, official adverse reaction reports have included difficulty falling asleep or staying asleep, known as insomnia, as an effect associated with this medication. This is a recognized change documented in product safety information.


Q: Are there any known allergic reactions associated with Nofertyl?

Yes, the official label states that the drug is contraindicated in patients who have a known history of anaphylactic reaction, angioedema, or a more general hypersensitivity to the active ingredients or any other component in the formulation.


Q: What happens if Nofertyl is taken past its expiration date?

Regulatory agencies specify that the safety and effectiveness of a medication cannot be guaranteed once it is taken past the printed expiration date. For this reason, expired medication should not be used. Disposal of unused or expired medication should follow local guidelines for pharmaceutical waste.


Q: Can Nofertyl be split or crushed for easier swallowing?

Official dosage and administration information typically requires that the oral tablet be swallowed whole to ensure the dose is delivered as designed. Unless the prescribing information specifically indicates that the tablets are scored and safe for splitting, manipulating the tablet (crushing or splitting) is generally not recommended.


Q: Is it possible to have a reaction to the inactive ingredients in Nofertyl?

Yes, official drug labels may carry specific warnings regarding some inactive ingredients, or excipients, used in the formulation. If a patient is known to be sensitive to certain dyes or fillers, an allergic-type reaction is possible.


Q: Are there any specific lifestyle changes recommended when starting Nofertyl?

While official labels do not explicitly 'prescribe' lifestyle changes, the safety warnings section emphasizes increased risks associated with factors like smoking and obesity. Addressing these factors is generally understood to be beneficial for overall cardiovascular health while receiving hormonal therapy.


Q: Why is Nofertyl prescribed instead of lifestyle changes alone?

Nofertyl is officially indicated for use when non-estrogen treatment options, which may include lifestyle changes, are considered unsuitable or insufficient. It is used to provide systemic hormonal restoration when the patient is at significant risk, such as for the prevention of osteoporosis or for treating moderate to severe vasomotor symptoms.


Q: What is the risk of withdrawal symptoms if Nofertyl treatment is ended?

The official product information does not explicitly define a 'withdrawal syndrome' for this type of hormone replacement therapy. However, when treatment is stopped, the symptoms that the drug was prescribed to control, such as hot flashes, may recur.


Q: Are there specific lab tests required before starting Nofertyl?

Regulatory guidance often advises that patients should be up-to-date with standard preventative screenings, such as mammography and cervical cytology, prior to starting therapy. Depending on the indication, baseline assessments of bone mineral density (BMD) or lipid profiles may also be considered.


Q: How long does it typically take to start feeling the intended effects of Nofertyl?

Clinical studies have examined the effectiveness of Nofertyl for its intended uses. Studies have shown that a reduction in the mean number and intensity of hot flushes compared to placebo may typically be observed starting around Week 4 of treatment.


How should Nofertyl be stored and disposed of?

Storage and Disposal of NOFERTYL

Official regulatory guidelines dictate specific storage and disposal requirements for Nofertyl (estradiol and norethisterone oral tablets) to maintain product quality and ensure safety.


Storage Requirements

Nofertyl must be stored at controlled room temperature, typically stipulated as not exceeding 25 C to 30 C. The product must be protected from moisture and direct light, requiring it to be kept in its original packaging (blister pack and outer carton) until administration. It is mandatory to keep the medication out of the sight and reach of children and do not freeze.


Disposal Instructions

Unused or expired Nofertyl must not be disposed of in household waste or flushed down the toilet. All disposal must be done according to local requirements for pharmaceutical waste, often involving collection programs through a pharmacy or authorized facility.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nofertyl found in:

A-Z Index: